Impact of pre-treatment derived neutrophil-lymphocyte-ratio on outcomes in patients with triple-negative breast cancer.

被引:0
|
作者
Sharma, Rakesh Kumar
Gogia, Ajay
Gupta, Ritu
Deo, S. V. S.
Sharma, Dayanand
Mathur, Sandeep
Sagiraju, Hari Krishna Raju
机构
[1] All India Inst Med Sci, Dr BRA Inst Rotary Canc Hosp, Dept Med Oncol, New Delhi, India
[2] All India Inst Med Sci, Dr BRAIRCH, New Delhi, India
[3] All India Inst Med Sci, Dr BRA Inst Rotary Canc Hosp, Dept Surg Oncol, New Delhi, India
[4] All India Inst Med Sci, Dr BRA Inst Rotary Canc Hosp, Dept Radiat Oncol, New Delhi, India
[5] All India Inst Med Sci, New Delhi, India
[6] All India Inst Med Sci AIIMS, Natl Canc Inst, Jhajjar, Haryana, India
关键词
D O I
10.1200/JCO.2021.39.15_suppl.e12556
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
e12556
引用
收藏
页数:3
相关论文
共 50 条
  • [31] Utility of pre-treatment neutrophil-lymphocyte ratio and platelet-lymphocyte ratio as prognostic factors in breast cancer
    Koh, C-H
    Bhoo-Pathy, N.
    Ng, K-L
    Jabir, R. S.
    Tan, G-H
    See, M-H
    Jamaris, S.
    Taib, N. A.
    [J]. BRITISH JOURNAL OF CANCER, 2015, 113 (01) : 150 - 158
  • [32] Time-Sequencing of the Neutrophil-to-Lymphocyte Ratio to Predict Prognosis of Triple-Negative Breast Cancer
    Kim, Joo-Heung
    Son, Nak-Hoon
    Lee, Jun-Sang
    Mun, Ji-Eun
    Kim, Jee-Ye
    Park, Hyung-Seok
    Park, Seho
    Kim, Seung-Il
    Park, Byeong-Woo
    [J]. CANCERS, 2021, 13 (14)
  • [33] Pretreatment neutrophil-to-lymphocyte ratio predicts lymph node metastasis in triple-negative breast cancer
    Philip, Arun
    Jose, Mathews
    Jose, Wesley
    Vijaykumar, D.
    Pavithran, Keechilat
    [J]. INDIAN JOURNAL OF CANCER, 2022, 59 (04) : 469 - 473
  • [34] Neutrophil-to-lymphocyte ratio predicts early mortality in females with metastatic triple-negative breast cancer
    de la Cruz-Ku, Gabriel
    Chambergo-Michilot, Diego
    Torres-Roman, J. Smith
    Rebaza, Pamela
    Pinto, Joseph
    Araujo, Jhajaira
    Morante, Zaida
    Enriquez, Daniel
    Flores, Claudio
    Luque, Renato
    Saavedra, Antonella
    Lujan, Maria
    Gomez, Henry
    Valcarcel, Bryan
    [J]. PLOS ONE, 2020, 15 (12):
  • [35] Prognostic significance of pre-treatment neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in locally advanced esophageal cancer.
    Clara, Joseph A.
    Kim, Dae Won
    Venkat, Puja
    Frakes, Jessica M.
    Hoffe, Sarah E.
    Almhanna, Khaldoun
    Kothari, Nishi
    Pena, Luis
    Pimiento, Jose Mario
    Kim, Richard D.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (04)
  • [36] Predictive value of neutrophil-lymphocyte ratio for the efficacy of preoperative chemotherapy in triple-negative breast cancer
    Asano, Yuka
    Kashiwagi, Shinichiro
    Morisaki, Tamami
    Noda, Satoru
    Kawajiri, Hidemi
    Takashima, Tsutomu
    Onoda, Naoyoshi
    Hirakawa, Kosei
    [J]. CANCER RESEARCH, 2015, 75
  • [37] Association of statin use with clinical outcomes in patients with triple-negative breast cancer.
    Nowakowska, Malgorzata
    Lei, Xiudong
    Thompson, Mikayla R.
    Shaitelman, Simona Flora
    Wehner, Mackenzie
    Woodward, Wendy A.
    Giordano, Sharon H.
    Nead, Kevin Thomas
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [38] Association of pre-treatment hemoglobin levels with survival outcomes among Indian women with triple negative breast cancer.
    Sagiraju, Hari Krishna Raju
    Gogia, Ajay
    Sharma, Rakesh Kumar
    Deo, S. V. S.
    Sharma, Dayanand
    Gupta, Ritu
    Mathur, Sandeep
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [39] Predictive value of neutrophil-to-lymphocyte ratio on pathological complete response in triple negative breast cancer.
    Enriquez, Daniel
    Ku, Gabriel Antonio De la Cruz
    Fernandez, Margiory
    Eyzaguirre, Eduardo
    Luque, Renato
    Paitan, David
    Lujan, Maria
    Saavedra, Antonella
    Valcarcel, Bryan
    Morante, Zaida
    Fuentes, Hugo Alejandro
    Neciosup, Silvia P.
    Gomez, Henry Leonidas
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [40] Chemotherapy-related outcomes in triple-negative breast cancer.
    Wellmann, Rebecca M.
    Ghafouri, Sanaz N.
    McAndrew, Nicholas Patrick
    Hurvitz, Sara A.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)